表紙
市場調查報告書

抗菌劑敏感性實驗的全球市場:2019年∼2023年

Global Antimicrobial Susceptibility Testing Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 877629
出版日期 內容資訊 英文 124 Pages
訂單完成後即時交付
價格
Back to Top
抗菌劑敏感性實驗的全球市場:2019年∼2023年 Global Antimicrobial Susceptibility Testing Market 2019-2023
出版日期: 2019年05月28日內容資訊: 英文 124 Pages
簡介

世界各國政府正採取各種舉措,提高最終用戶對藥物對治療病原體感染的影響的認識。這些舉措提供監管機構,決策者和其他最終用戶關於預防疾病發生率的重要訊息。例如,印度啟動了國家遏制抗菌素耐藥性計劃,作為其在國家建立基於實驗室的AR監測系統的第12個五年計劃的一部分,並提高醫療服務提供者對AR的認識。在預測期內,此類舉措正加速全球抗菌劑敏感性測試市場的成長,年複合成長率超過5%。

本報告提供全球抗菌劑敏感性測試市場調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各應用領域

  • 市場區隔:各應用領域
  • 各應用領域比較:市場規模及預測(2018年∼2023年)
  • 臨床診斷
  • 藥物研發與開發
  • 其他
  • 市場機會:各應用領域

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

第12章 業者情勢

  • 概要
  • 創造性破壞狀況

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR31377

About this market

Antimicrobial susceptibility testing is used to determine the presence of bacteria and fungi in the body. Technavio's antimicrobial susceptibility testing market considers the application of antimicrobial susceptibility testing in clinical diagnostics, drug discovery and development, and others. Our analysis also considers the application of antimicrobial susceptibility testing in Asia, Europe, North America, and ROW. In 2018, the clinical diagnostics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the growing awareness of personalized medicine will play a significant role in the clinical diagnostics segment to maintain its market position. Also, our global antimicrobial susceptibility testing market looks at factors such as increased use of antimicrobial susceptibility testing by pharmaceutical companies, increasing the prevalence of infectious diseases, and increasing government initiatives. However, stringent government regulatory policies, challenges associated with antimicrobial susceptibility testing, and optimization of target product profiles may hamper the growth of the antimicrobial susceptibility testing industry over the forecast period.

Overview

Increasing government initiatives

Governments across the world are undertaking various initiatives to create awareness among end-users about the effects of drugs on treating infections caused by pathogens. These initiatives are providing critical information to regulatory agencies, decision makers, and other end-users about the prevention of the incidences of diseases. For instance, India launched the National Programme on Containment of Antimicrobial Resistance as part of its 12th five-year plan to establish a laboratory-based AR surveillance system in the country and to create awareness among healthcare providers about AR. Such initiatives are accelerating the growth of the global antimicrobial susceptibility testing market at a CAGR of over 5% during the forecast period.

Increasing use of antibiograms

Antibiograms help in tracking local antibiotic resistance trends and improve the ability to avoiding suboptimal therapies and provide better patient care. They are also used as a tool in developing guidelines for empiric therapy and to make formulary decisions and monitor resistance rates. Despite high costs and complexities associated in the construction of antibiograms, their demand in the antimicrobial susceptibility testing industry is expected to increase over the forecast period.

For the detailed list of factors that will drive the global antimicrobial susceptibility testing market size during the forecast period 2019-2023.

Competitive Landscape

With the presence of several players, the global antimicrobial susceptibility testing market is moderately concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several antimicrobial susceptibility testing companies, that include bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., Merck KGaA, and Thermo Fisher Scientific Inc.

Also, the antimicrobial susceptibility testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • Clinical diagnostics - Market size and forecast 2018-2023
  • Drug discovery and development - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Application - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by application
  • Exhibit 19: Clinical diagnostics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Clinical diagnostics - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Drug discovery and development - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Drug discovery and development - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by application
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Examples of infectious diseases caused by pathogenic microorganisms
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: bioMerieux SA - Vendor overview
  • Exhibit 47: bioMerieux SA - Business segments
  • Exhibit 48: bioMerieux SA - Organizational developments
  • Exhibit 49: bioMerieux SA - Geographic focus
  • Exhibit 50: bioMerieux SA - Key offerings
  • Exhibit 51: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 52: Bio-Rad Laboratories Inc. - Product segments
  • Exhibit 53: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 54: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 55: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 56: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 57: Danaher Corp. - Vendor overview
  • Exhibit 58: Danaher Corp. - Business segments
  • Exhibit 59: Danaher Corp. - Organizational developments
  • Exhibit 60: Danaher Corp. - Geographic focus
  • Exhibit 61: Danaher Corp. - Segment focus
  • Exhibit 62: Danaher Corp. - Key offerings
  • Exhibit 63: Merck KGaA - Vendor overview
  • Exhibit 64: Merck KGaA - Business segments
  • Exhibit 65: Merck KGaA - Organizational developments
  • Exhibit 66: Merck KGaA - Geographic focus
  • Exhibit 67: Merck KGaA - Segment focus
  • Exhibit 68: Merck KGaA - Key offerings
  • Exhibit 69: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 70: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 71: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 74: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 75: Validation techniques employed for market sizing
  • Exhibit 76: Definition of market positioning of vendors
Back to Top